Antex Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 05-07-2024
- Paid Up Capital ₹ 7.00 M
as on 05-07-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 Cr
as on 05-07-2024
- Satisfied Charges ₹ 8.25 Cr
as on 05-07-2024
- Revenue -19.08%
(FY 2023)
- Profit 42.37%
(FY 2023)
- Ebitda 24.79%
(FY 2023)
- Net Worth 34.73%
(FY 2023)
- Total Assets 3.84%
(FY 2023)
About Antex Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹5.50 Cr. The company has closed loans amounting to ₹8.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Tiwari and Amardeep Bansal serve as directors at the Company.
- CIN/LLPIN
U24100DL2009PTC188276
- Company No.
188276
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Antex Pharma Private Limited offer?
Antex Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Antex Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Tiwari  | Additional Director | 12-Dec-2019 | Current |
| Amardeep Bansal | Director | 06-Mar-2009 | Current |
Financial Performance of Antex Pharma.
Antex Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.08% decrease. The company also saw a substantial improvement in profitability, with a 42.37% increase in profit. The company's net worth Soared by an impressive increase of 34.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Antex Pharma?
In 2023, Antex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shell Agro Infrastructure Private LimitedActive 14 years 8 monthsAmardeep Bansal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 18 Oct 2023 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Oct 2020 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 02 Jul 2015 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Antex Pharma?
Unlock and access historical data on people associated with Antex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antex Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
